Catawba Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$1.27M Buy
14,883
+2,240
+18% +$184K 0.3% 78
2018
Q1
$978K Buy
12,643
+570
+5% +$45.9K 0.23% 92
2017
Q4
$1.02M Sell
12,073
-100
-0.8% -$8.51K 0.23% 92
2017
Q3
$1.04M Buy
12,173
+1,590
+15% +$130K 0.24% 93
2017
Q2
$871K Buy
10,583
+1,575
+17% +$128K 0.2% 107
2017
Q1
$758K Buy
9,008
+1,210
+16% +$96.9K 0.17% 128
2016
Q4
$574K Sell
7,798
-100
-1% -$7.45K 0.13% 136
2016
Q3
$634K Hold
7,898
0.15% 134
2016
Q2
$622K Buy
7,898
+250
+3% +$18.8K 0.15% 129
2016
Q1
$551K Sell
7,648
-2,740
-26% -$207K 0.14% 132
2015
Q4
$875K Hold
10,388
0.24% 98
2015
Q3
$869K Sell
10,388
-2,900
-22% -$245K 0.24% 97
2015
Q2
$1.11M Sell
13,288
-520
-4% -$39.6K 0.26% 89
2015
Q1
$1M Buy
13,808
+680
+5% +$48.4K 0.23% 101
2014
Q4
$906K Sell
13,128
-40
-0.3% -$2.7K 0.21% 106
2014
Q3
$854K Hold
13,168
0.2% 111
2014
Q2
$819K Hold
13,168
0.18% 117
2014
Q1
$775K Sell
13,168
-250
-2% -$14K 0.18% 110
2013
Q4
$684K Hold
13,418
0.16% 123
2013
Q3
$675K Hold
13,418
0.18% 120
2013
Q2
$659K Buy
+13,418
New +$730K 0.18% 113

Other funds holding LLY

Catawba Capital Management's LLY Position: Q2 2018 in Review

Catawba Capital Management increased its Eli Lilly (LLY) stake by 18% in Q2 2018, buying an estimated $184K and bringing the position to 14,883 shares worth $1.27M. The position accounts for 0.3% of the portfolio, ranked #78.

Catawba Capital Management first reported a position in LLY in Q2 2013 and has held it in 21 quarters since. 1,368 funds tracked by Wall St. Rank hold LLY as of Q2 2018.

  • Catawba Capital Management held 14,883 shares of Eli Lilly worth $1.27M as of Q2 2018.
  • Catawba Capital Management bought 2,240 Eli Lilly shares in Q2 2018, an estimated $184K.
  • Eli Lilly made up 0.3% of Catawba Capital Management's portfolio in Q2 2018, its #78 holding.
  • Catawba Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 21 quarters since.
  • 1,368 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.

Based on Catawba Capital Management's 13F filing for Q2 2018, filed 11 Jul 2018.